SNP | Genotypes | Age at diagnosis (years) | p value | BMI (Mean ± SD) | p value | Gender | p value | ||
---|---|---|---|---|---|---|---|---|---|
Male | Female | ||||||||
PDL-1 rs4143815 C/G | General | CC | 4.15 ± 0.07 | NA | 44.6 ± 0.0 | NA | 0 (0%) | 2 (3.8) | NA |
CG | 2.71 ± 0.53 | 17.9 ± 2.4 | 14 (50%) | 16 (30.8%) | |||||
GG | 2.48 ± 0.61 | 18.5 ± 3.2 | 14 (50%) | 34 (65.4%) | |||||
Dominant | CC | 4.15 ± 0.07 | NA | 44.6 ± 0.0 | NA | 0 (0%) | 2 (3.8) | NA | |
CG + GG | 2.97 ± 0.58 | 18.3 ± 2.9 | 28 (100%) | 50 (96.2%) | |||||
Recessive | GG | 2.84 ± 0.61 | 0.771 | 18.5 ± 3.2 | 0.372 | 14 (50%) | 34 (65.4%) | 0.180 | |
CG + CC | 2.80 ± 0.63 | 19.5 ± 7.0 | 14 (50%) | 18 (34.6%) | |||||
PDL-1 rs2297137 A/G | General | AA | 2.20 ± 0.14 | NA | 25.0 ± 0.0 | NA | 0 (0%) | 2 (3.8%) | NA |
GA | 2.89 ± 0.61 | 20.3 ± 7.7 | 12 (42.9%) | 12 (23.1%) | |||||
GG | 2.82 ± 0.62 | 18.1 ± 3.0 | 16 (57.1%) | 38 (73.1%) | |||||
Dominant | AA | 2.20 ± 0.14 | NA | 25.0 ± 0.0 | NA | 0 (0%) | 2 (3.8%) | NA | |
GA + GG | 2.84 ± 0.61 | 18.8 ± 5.0 | 28(100%) | 50 (96.2%) | |||||
Recessive | GG | 2.82 ± 0.62 | 0.897 | 18.1 ± 3.0 | 0.109 | 16 (57.1%) | 38 (73.1%) | 0.147 | |
GA + AA | 2.83 ± 0.61 | 20.6 ± 7.5 | 12 (42.9%) | 14 (26.9%) |